Sale!

MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the MYLK gene associated with familial thoracic aortic aneurysms. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variations that predispose individuals to life-threatening aortic conditions. The test is crucial for individuals with family history of aortic dissections, sudden cardiac deaths, or connective tissue disorders. Results provide valuable information for preventive care, surgical planning, and family screening. With results available in 3-4 weeks from blood or DNA samples, this test offers peace of mind and proactive health management. The discounted price is $500 USD, providing affordable access to advanced genetic diagnostics.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 NGS Genetic DNA Test

Understanding Thoracic Aortic Aneurysm and the MYLK Gene

Thoracic aortic aneurysm represents a serious medical condition where the main artery carrying blood from the heart weakens and bulges, creating a life-threatening risk of rupture or dissection. The MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 NGS Genetic DNA Test specifically examines mutations in the MYLK (myosin light chain kinase) gene, which plays a critical role in regulating vascular smooth muscle contraction and aortic wall integrity.

This advanced genetic test is particularly important because familial thoracic aortic aneurysms often remain asymptomatic until catastrophic events occur. By identifying genetic predispositions early, individuals can implement preventive measures and monitoring protocols that significantly reduce mortality risks associated with this silent but deadly condition.

What Does the Test Detect?

The MYLK Gene Aortic Aneurysm Test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the entire MYLK gene for pathogenic variants. This sophisticated approach detects:

  • Point mutations affecting MYLK gene function
  • Small insertions and deletions that disrupt protein production
  • Genetic variations associated with impaired vascular smooth muscle function
  • Hereditary mutations passed through family generations
  • Specific variants linked to thoracic aortic dissection risk

The test provides a complete genetic profile of an individual’s susceptibility to developing thoracic aortic aneurysms, enabling personalized medical management and family screening recommendations.

Who Should Consider This Genetic Test?

Primary Candidates for Testing

This genetic test is particularly recommended for individuals who meet any of the following criteria:

  • Family history of thoracic aortic aneurysms or dissections
  • Relatives diagnosed with familial thoracic aortic aneurysm type 7
  • Unexplained sudden cardiac deaths in the family
  • Personal history of connective tissue disorders
  • Multiple family members with aortic surgery
  • Young individuals (under 50) with aortic enlargement
  • Those planning pregnancy with family history of aortic disease

Clinical Symptoms and Indicators

While thoracic aortic aneurysms often present without symptoms, certain warning signs may indicate the need for genetic testing:

  • Chest, back, or jaw pain without cardiac cause
  • Hoarseness or difficulty swallowing
  • Shortness of breath or coughing
  • Pulsating sensation in the chest
  • Family members with Marfan-like features
  • Unexplained aortic dilation on imaging studies

Benefits of MYLK Genetic Testing

Undergoing the MYLK Gene Aortic Aneurysm Test provides numerous advantages for both patients and their families:

Early Risk Identification

Genetic testing allows for the identification of at-risk individuals before symptoms develop, enabling proactive monitoring and preventive interventions that can save lives.

Personalized Medical Management

Positive test results guide healthcare providers in developing tailored surveillance plans, including appropriate imaging frequency and blood pressure management strategies.

Family Screening Opportunities

Identifying a genetic mutation enables targeted testing of family members, potentially preventing catastrophic aortic events across generations.

Surgical Planning Guidance

For individuals requiring aortic surgery, genetic information helps determine optimal timing and surgical approach based on individual risk profiles.

Reproductive Decision Support

Couples can make informed family planning decisions with knowledge of inheritance patterns and potential genetic risks to offspring.

Understanding Your Test Results

Possible Result Interpretations

Your genetic test results will fall into one of several categories, each with specific implications:

  • Positive Result: A pathogenic mutation in the MYLK gene is identified, confirming increased risk for thoracic aortic aneurysm. This result necessitates regular cardiovascular monitoring and may influence treatment decisions.
  • Negative Result: No disease-causing mutations are detected in the MYLK gene. However, this does not completely eliminate aortic disease risk, as other genetic or environmental factors may contribute.
  • Variant of Uncertain Significance (VUS): A genetic change is identified, but its clinical significance is unknown. Ongoing research may provide clarification over time, and family studies might help determine pathogenicity.
  • Benign Variant: Genetic changes that are not associated with disease risk are identified and documented for future reference.

Post-Test Recommendations

Regardless of your test outcome, comprehensive genetic counseling is essential to fully understand the implications of your results and develop an appropriate management plan. Our genetic specialists provide detailed explanations and coordinate with your healthcare team to ensure optimal care.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas. Our state-of-the-art facilities in New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities ensure accessible genetic testing services for everyone.

Each location maintains the highest standards of laboratory excellence and patient care, with certified genetic counselors and medical professionals available to support you throughout the testing process.

Take Control of Your Cardiovascular Health

Don’t wait for symptoms to appear. Proactive genetic testing for thoracic aortic aneurysm risk can provide life-saving information for you and your family. Our comprehensive MYLK gene testing offers the most advanced genetic analysis available, backed by expert interpretation and ongoing support.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic risk and protecting your cardiovascular health for years to come.

Our team is available to answer your questions, discuss insurance coverage options, and guide you through the pre-test genetic counseling process. Early detection through genetic testing represents the future of preventive medicine – embrace this opportunity to safeguard your health and your family’s wellbeing.